A Case of Organizing Pneumonia (OP) Associated with Pembrolizumab
Until recently, chemotherapy for metastatic melanoma had disappointing results. The identification of immune checkpoints such as CTLA-4 and PD-1/PD-L1 has led to the development of an array of monoclonal antibodies (Mabs). These immunologic approaches against tumoral cells come with a novel kind of...
Main Authors: | , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
AboutScience Srl
2016-05-01
|
Series: | Drug Target Insights |
Subjects: | |
Online Access: | https://journals.aboutscience.eu/index.php/dti/article/view/1420 |